Methods Families are selected by family history, pre-treatment blood pressure readings (recorded by their GP), BMI and self reported alcohol consumption. Each family is extensively phenotyped in either their home or at their GP surgery. Families are given a unique identification number, family history and individual lifestyle are recorded and then stored in an anonymised, computerised database. Current
Further validation of a semi-automatic blood pressure machine (OMRON HEM-705CP) with an assessment of its use in a hypertension unit and preliminary findings in a general medical ward ND Markandu, S Duneclift, C Carney and A Arnold Blood Pressure Unit, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK Background Mercury sphygmomanometers are likely to be phased out in the near future. Although several automatic blood pressure machines are now available on the market, few of them have been properly validated. The OMRON HEM-705CP, an oscillometric semi-automatic machine, has been validated using both the British Hypertension Society and the American Standard Guidelines. However, it has not been tested over a wide range of blood pressure for accuracy and no practical blood pressure, height, weight, anthropometric (waist/hip ratio), 12-lead ECG, 24-h ambulatory blood pressure measurements are recorded. A blood sample is taken for genetic screening and biochemistry including: urea, creatinine, plasma urate, lipids. A 24-h urine collection is made for microalbuminuria and sodium/potassium excretion. Echocardiography is offered to individuals wishing to travel to their local centre. In 1997 we commenced genomic screening of 164 families.
Results By March 1999 we have collected over 1050 families of white European ancestry. These families comprise at least two or more affected hypertensive siblings. Provisional results from the first screen of 164 families are: number of females = 224 and males = 125. Mean pre-diagnosis systolic 172 and diastolic 105. Mean systolic at phenotyping 154 mm Hg and diastolic 95 mm Hg. Systolic in top 5% of distribution 92% and diastolic 88%. Systolic in top 1% 78% and diastolic 51%. Percentage of those with ABP records 90%. Mean BMI 27 kg/m 2 . Mean waist/hip ratio 0.96. Mean alcohol intake (units/week) female 3, male 9. Genome screen 2 of a further 350 families commenced December 1998. assessment of the use of the machine in a hypertension unit has been published.
Method
The OMRON was compared with a mercury sphygmomanometer via a Y connector. Two nurses recorded the sphygmomanometer readings independent of each other using a double-headed stethoscope. The third nurse recorded the OMRON readings. Subjects were studied with a very wide range of blood pressure. In 85 subjects three con-Journal of Human Hypertension secutive measurements were made and in 244 subjects a single reading was made in each.
Results Systolic blood pressure ranged from 94 to 240 mm Hg and diastolic from 56 to 143 mm Hg. The readings in the 85 subjects compared with the nurses readings showed a mean difference of 0.49 mmHg systolic (s.d. ± 6.53 mm Hg) and −2.00 mm Hg diaastolic (s.d. ± 5.80 mm Hg). In the larger group of subjects who were compared, it gave similar results 1.31 mm Hg (s.d. ± 6.65) for systolic and −1.52 mm Hg (s.d. ± 6.34) for diastolic. Since establishing the accuracy of the OMRON is has been used as a routine measurement of blood pressure in all patients in the Blood Pressure Unit. During this time it has shown itself to be a reliable machine with no mechanical failures. At the same time it has been widely used by patients at home where again, it has performed satisfactorily. In view of these findings it was decided to replace the mercury sphygmoman-
Factors influencing the patient's knowledge about hypertension
L Płaszewska-Ż ywko 1 and T. Grodzicki Objective The aim of the study was to evaluate the level of knowledge about hypertension (HTN) that exists within the adult population of hypertensives and to answer the question whether there is a difference in patients' knowledge related to age, sex, educational status, duration of treatment and occurrence of HTN in patients' families. Background Hypertension is a known risk factor for coronary heart disease and stroke. Non-pharmacological intervention, particularly reduction in salt intake, increased physical activity and weight control, are known to reduce blood pressure (BP). However, in practice, adherence to such measures is poor, and there is little published information as to how such therapy can best be delivered. We have recently established a 10-week programme of nonpharmacological therapy, specifically designed for hypertensive patients, which consists of physical activity, dietary advice and stress management. We wished to study the effectiveness of this programme in reducing both BP and body mass index (BMI). We recruited 25 patients (12 male, 13 female), 34 -78 years of age. Of these, six were excluded because of pregnancy or changes to medications during the study period. Nineteen patients (9 male, 10 female) completed the study. BP was measured at baseline and following completion of the programme and was measured by mercury sphygmomanometry by a single trained observer. BMI was also calculated at Preoperative blood pressure (BP) measurement is routine practice prior to surgery in order to assess any potential risk for anaesthesia. Deferred or cancelled surgical procedures due to high BP are a common clinical situation. We therefore undertook a questionnaire survey in a single teaching hospital anaesthetic unit on how preoperative BP was measured and the specific BP thresholds considered to warrant operation deferral. A standardised questionnaire survey was completed by 30 (training grade and consultant) anaesthetists. Over 80% of respondents would use either
Patients and methods
Journal of Human Hypertension the same time points. We compred data from these actively treated patients with a group of 18 historical controls (6 males, 12 females, aged 31-71 years). Comparison were made using paired Student's ttest, statistical significance was taken as P Ͻ 0.05 (two-tailed). All results shown are as mean ± s.e.m.
Results Nineteen patients entered into the active treatment arm, and another 18 served as controls. Baseline BP was similar in both groups (systolic BP: controls 146.2 ± 4.0, active, 147.7 ± 2.9; diastolic BP: controls 88.9 ± 1.5, active 90.2 ± 1.4). BP did not change over the course of the 10 weeks in the control group. By contrast, systolic and diastolic BP decreased significantly in the actively treated patients, over the 10 weeks of treatment. BMI did not change significantly in either group (Figure 1 ).
Conclusion A lifestyle and exercise programme such as ours for the management of hypertension can effectively reduce BP. However further work is required in the form of a larger randomised controlled trial to confirm these findings.
the BP recorded in the patient notes or the beside record, while only 17% would undertake the BP measurement themselves. A large BP cuff (for a large arm) was used by only 17%, with similar numbers of the respondents (43%) measuring the BP in either the sitting or the lying position. Half the respondents would have measured the BP with a mercury column sphygmomanometer, the remainder with an automated device. Less than one-third (27%) would repeat BP measurements two or three times. A 'high diastolic' compared to 'high systolic' recording would favour cancellation (70% vs 43%). The recent major outcome trials in diabetic hypertension have highlighted the need for combination antihypertensive therapy in order to achieve a lower blood pressure (BP) and reduce cardiovascular complications. To date there is little data on the role of moxonidine in combination for the treatment of hypertension in patients with diabetes. In a cross-over study, eight patients with type 2 diabetes and on a conventional dose ACE1 for hypertension (mean BP: 176/93, s.d. 26/6), were assessed three times: (1) after a 2-week run-in phase, with continuation of conventional dose ACE1; (2) at the end of a 4-week low dose moxonidine (200 g), This study has shown large variations in measurement technique and 'safe thresholds'. Guidelines may play a role in the appropriate management and preoperative assessment of patients with raised arterial pressures. materials and invited by letter to return similar questionnaires and comments.
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Results All nurses attempted to complete their unit in the allocated time. The questionnaires provided generally positive data, eg, 100% of nurses felt they had gained knowledge and 67% felt the level of education to be satisfactory; 93% would recommend the materials to other nurses; 59% of nurses had difficulty accessing essential reading. In the semi-structured interviews topics included text size, self assessment, time to study. One hundred percent of nurses felt the materials would result in improved patient care. Less than 50% of the experts completed the questionnaires but 74% provided constructive comments.
Conclusion
The results suggest that these distance learning materials was acceptable to nurses preparing for the impact of clinical governance in primary care. The materials are to become an integral part of a year long distance learning course for nurses wishing to develop a specialist knowledge on managing cardiovascular disease. combination with half-dose ACE1 treatment; and (3) at the end of a 4-week treatment period with original dose ACE1 only. Standardised clinic BP measurements confirmed a mean reduction of 14/12 mm Hg (⌬ dBP P Ͻ 0.05 Wilcoxon) with low dose combination therapy and a 14/9 mm Hg increase (⌬ sBP, dBP, P Ͻ 0.01) after moxonidine withdrawal and reintroduction of the usual dose ACE1. There were no significant changes in weight or fasting glucose or lipid profile.
Several key pathophysiological determinants of BP such as sympathetic and RAS responsiveness are exaggerated in diabetes and may be key therapeutic targets for new antihypertensive treatments. Moxonidine is the first in a class of selective imidazoline (1-1 ) receptor agonists to be used in the UK. This study has shown the marked BP lowering effects of
Recruitment of older subjects to a hypertension trial from primary care
A Kulkarni, F Harrington, J Logan, BK Saxby, GA Ford and OFW James Institute for the Health of the Elderly, University of Newcastle Upon Tyne, UK Introduction The applicability of trial results to clinical practice is dependent upon recruiting subjects representative of the patient population. Many studies describe difficulties in recruiting older people, consequently the generalisability of many hypertension trials to routine clinical care of older people has been questioned. We describe experience in recruiting older subjects from primary care into a placebo-controlled trial examining blood pressure lowering effects on cardiovascular events and cognitive function.
Methods
The study on Cognition and Prognosis in the Elderly (SCOPE) recruited subjects 70-89 years of age, blood pressure 160-179 mm Hg systolic and/or 90-99 mm Hg diastolic, untreated or thiazide treated, without pre-existing cognitive impairment. The research team consisted of a Clinical Research Associate, two research nurses and a part time research assistant. Ten local general practices participated. Research staff screened primary care notes to identify potentially eligible untreated or thiazide treated subjects. Subjects were invited to participate by a letter from their general practitioner.
Medication discrepancies J Bunker, W Callister, P Sever and S Thom
The Peart Rose Clinic, St Mary's Hospital, South Wharf Road, London W2 1NY, UK Background Patients in a specialist hypertension clinic are instructed to bring all their prescribed drugs to each visit. At the end of the consultation the clinic doctor writes to the GP stating all current drug details and changes made. This is a complex loop between clinic instructions, Consultants treatment, hospital pharmacy, GP, community pharmacy, the patient and the return to the clinic. There are many steps where the loop can break down. To evaluate the efficiency of the loop and to establish the frequency with which the loop breaks down we looked at discrepancies between drugs taken by the patient and those prescribed by the doctors. Patients were asked to bring all their drugs to each visit and the nurse compared these with the most recent letter to the GP. Patients were asked about drug name, dose, frequency, time the drug was taken, and the purpose for which it was prescribed. New patients and patients who visited other outpatient clinics Journal of Human Hypertension combining a low dose imidazoline agonist and ACE1, as well as the effects of monotherapy withdrawal. This combination has the potential advantage of minimising drug related side effects.
Results A total of 8593 patient records were screened: 2378 potentially eligible subjects were identified: 969 (41%) were not interested in entering the study; 611 (25%) did not reply; 798 (34%) attended the research centre clinic for an initial visit. Of those seen at the clinic 420 (53%) were excluded primarily because blood pressure entry criteria were not met; 378 (47%) enrolled in the study. Of those enrolled, 121 withdrew during the run-in phase leaving 257 (11% of potentially eligible subjects) randomised. Characteristics of randomised subjects were: mean age 76 years, blood pressure 165/88 mm Hg, 54% female, previous stroke 8%, previous myocardial infarction 4%, atrial fibrillation 4%, diabetes 2%, peripheral vascular disease 7%. Recruitment was helped by research staff screening notes, the initial approach from the general practitioner, and provision of transport to subjects.
Conclusions
Recruitment of large numbers of older people, reasonably representative of the general population, into intervention trials is feasible from primary care with research team support.
were excluded. Blood pressure was considered poorly controlled if the systolic was greater than 160 mm Hg, and diastolic greater than 90 mm Hg and well controlled if the systolic was equal to or less than 135 and the diastolic equal to or less than 80 mm Hg.
Results There were 91 female and 82 male patients ranging from 19 to 85 years (median 59). Systolic blood pressure ranged from 103 to 214 mm Hg (median 146), and diastolic from 53 to 127 mm Hg (median 87). The patients were taking from one to 11 drugs each (median 3). Although all patients were asked to bring all their drugs only 53 (30%) brought all, 22 (13%) brought some and 98 (57%) brought none. For 88 (51%) patients there was a discrepancy between the drugs they were taking and those written in the last clinic letter; 58 (34%) had no discrepancies, and in the remaining 27 (16%) we Journal of Human Hypertension had no way of knowing. We looked at where the breakdown in the loop occurred, 24 (27%) patients had no more than one break in the loop: 21 breaks were attributable to the clinic, 42 to the patient, 11 to the GP, three to the pharmacy, one typing error and 35 don't know. A total of 37 (42%) of the 88 were taking additional drugs that were not recorded in the last clinic letter, 10 of whom were taking antihypertensive drugs. There appeared to be no relationship between level of blood pressure control and the number of discrepancies or whether they had brought their drugs to the clinic visit. The nurses made a subjective judgement on how competent the patient was in reporting their drug details A questionnaire to assess nursing staff attitudes towards the use of automated devices for the measurement of blood pressure Background Mercury sphygmomanometry has been in use for blood pressure (BP) measurement for over a century and remains the gold standard. However, mercury is gradually being replaced leading to the increased use of automated BP devices. A pilot study involving Guy's, St Thomas', Lewisham and King's College staff, mainly nursing staff, showed that 73% preferred using automated BP devices of these 50% used the Dinamap 8100 which failed the BHS validation protocol (O'Brien et al, J Hypertens 1993; 11: 761-763). Many staff using it were unaware of any validation protocol and continued to use it over the use of mercury sphygmomanometry. The move to eliminate mercury has raised awareness of inaccuracy problems relating to BP devices currently in use. The following study will look at why certain devices are being used and what influenced their use. Objective An exaggerated rise in diastolic blood pressure (DBP) during exercise is seen in hypercholesterolaemia and may reflect impaired vasodilatation of resistance vasculature within skeletal muscle (Brett et al, Circulation 2000; 101: 611-615) . We investigated whether a similar increase in exercise DBP occurs in subjects with essential hypertension.
Design and methods
We measured blood pressure during exercise in three groups of consecutively recruited asymptomatic active men; normotensive using a scale 1 to 6, 6 being very competent. For the 28 patients in the uncontrolled blood pressure group, eight (29%) were on scale 6, for the 24 patients in the controlled group 11 (46%) were on scale 6.
Conclusion
In the setting of a specialist hypertension clinic, for more than 50% of patients there is a discrepancy between the drugs the patients are taking and those the clinic doctors think they should be taking. From the disappointing results of this audit, improvements in methods of communication involving patient, physician, GPs and pharmacists are mandatory.
Methods A BP measurement questionnaire will be distributed to hospital and primary care nurses. Likert scales will be used to measure response rates which will then be analysed, using analysis of variance (ANOVA).
Expected outcomes
To provide information on current purchasing trends for BP devices and to assess why certain devices are currently being used.
Conclusion
Inaccurate BP measurement can lead to inappropriate care. The information gained could be used to develop a number of recommendations for change in Hospital and Community Trusts' future policies on staff training and the purchasing of BP devices. normocholesterolaemic (total cholesterol Ͻ6.0 mmol/L) men (NC, n = 17, mean age ± s.d. 38 ± 6 years); untreated mild hypertensive (as defined by WHO/ISH guidelines), normocholesterolaemic (HBP, n = 17, 38 ± 6 years); Normotensive, hypercholesterolaemic (total cholesterol Ͼ6 mmol/L) men (HC, n = 17, 37 ± 7 years). BP was measured by mercury sphygmomanometer (Korotkoff phases I and IV) after 30 min at rest and during fixed workload bicycle ergometry (50, 75 and 100 watts, each for 3 min) by a single trained observer. Differences in exercise BP and the change in BP from resting values were sought using analysis of variance for repeated measures.
Results
The mean increase, from resting values, in DBP (⌬DBP) for all work loads in HBP (4.4 ± 1.3 mm Hg, mean ± s.e.) was similar to that in HC (5.4 ± 1.5 mm Hg). ⌬DBP in both HBP and HC was significantly greater than in NC (0.5 ± 1.1 mm Hg, P Ͻ 0.05 in both cases). There was no significant differBlood pressure control within the MRC British Genetics of Hypertension Study Background The MRC British Genetics of Hypertension Study (MRC BRIGHT Study) was set up in 1996 and aims to identify the major genes for high blood pressure. A total of 1500 white European families based upon affected sibling pairs with essential hypertension are being collected over a 4-year period. Recruitment is co-ordinated by one study nurse co-ordinator and 15 nurses based within the centres.
In this study we utilised data from our phenotypic database to evaluate the numbers of affected subjects identified from primary care which met with BHS National Guidelines for optimal treatment.
Methods
The families are primarily identified using the MRC General Practice Framework and have pre-diagnosed blood pressures in the upper 5% of the blood pressure distribution. All sib pairs have been extensively phenotyped by 15 trained MRC Study nurses based in the six-centre consortium. Hypertensive families conforming to BRIGHT criteria, according to standard operating procedures, are phenotyped with family history of cardiovascular disease, socioeconomic status, anthropomorphic measurements, 12-lead ECG, echocardiography, biochemistry, lipids and 24-h creatinine clearance and protein loss. Three blood pressures at phenotyping, using the OMRON HEM 705CP, appropriate cuff size and seated position after a period of rest were recorded. A custom built Microsoft Access Database conforming to the Data Protection Act was designed in 1998. Affected sibling pair phenotyping data is held in the database using unique family identification codes. The family structure is entered using linkage format. Since our study is mainly based
Journal of Human Hypertension ence in the increase in systolic BP at any work load between the groups.
Conclusion
Men with untreated essential hypertension show the same pattern of BP response to low work load exercise as normotensive men with raised serum cholesterol. These findings may reflect impaired vasodilation of resistance vessels during exercise in men with hypertension.
upon affected sibling pairs we developed additional checks using purpose written Microsoft Access database to give added quality assurance. Data is double entered to exclude data entry bias or general mistakes. A merge programme is currently linking both sets of data together to provide one corrected and complete phenotypic database. In 1999 BHS Guidelines proposed a minimum audit standard of 150/85 mm Hg for blood pressure control. The guidelines further proposed optimal blood pressure levels should be less than 140/85 mm Hg for a non-diabetic hypertensive on treatment.
Provisional results and conclusion From a collection of 1853 affected individuals in the database comprising 756 males and 1097 females the following provisional results were obtained. Compared to current British Hypertension Society (BHS) guidelines for non-diabetic hypertensive patients our provisional data suggests that only 8.1% of males and 14.6% of females meet with the optimal clinic blood pressure of Ͻ140/85 mm Hg. Furthermore, only 20.5% of males and 29.1% of females meet with the Audit Standard of 150/90. We are currently trying to narrow this down with geographical location to identify whether blood pressure is better in some parts of the country. The data from the BRIGHT Study subjects suggests that blood pressure control of severely affected hypertensives drawn from the upper 5% of the distribution fails to meet with current BHS standards for audit and optimal control. Further screening may define other phenotypes, which correlate with poor blood pressure control.
